CiteULike
Facebook
Mendeley
Twitter
This article is- freely available
- re-usable
Cancers 2011, 3(1), 1232-1252; doi:10.3390/cancers3011232
Review
Cancer Stem Cell Radioresistance and Enrichment: Where Frontline Radiation Therapy May Fail in Lung and Esophageal Cancers
1
Balliol College, University of Oxford, Oxford, UK
2
Department of Pharmaceutical and Biomedical Sciences, College of Pharmacy, University of Georgia, Athens, Georgia 30602, USA
3
Department of Radiation Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030, USA
* Author to whom correspondence should be addressed.
Received: 7 December 2010; in revised form: 25 January 2011 / Accepted: 24 February 2011 / Published: 10 March 2011
(This article belongs to the Special Issue Cancer Stem Cells)
Download PDF Full-Text [1331 KB, uploaded 10 March 2011 10:02 CET]
Abstract: Many studies have highlighted the role cancer stem cells (CSC) play in the development and progression of various types of cancer including lung and esophageal cancer. More recently, it has been proposed that the presence of CSCs affects treatment efficacy and patient prognosis. In reviewing this new area of cancer biology, we will give an overview of the current literature regarding lung and esophageal CSCs and radioresistance of CSC, and discuss the potential therapeutic applications of these findings.
Keywords: cancer stem cells; lung cancer; esophageal cancer; radiation therapy
Article Statistics
Click here to load and display the download statistics.Cite This Article
MDPI and ACS Style
Nguyen, G.H.; Murph, M.M.; Chang, J.Y. Cancer Stem Cell Radioresistance and Enrichment: Where Frontline Radiation Therapy May Fail in Lung and Esophageal Cancers. Cancers 2011, 3, 1232-1252.
AMA StyleNguyen GH, Murph MM, Chang JY. Cancer Stem Cell Radioresistance and Enrichment: Where Frontline Radiation Therapy May Fail in Lung and Esophageal Cancers. Cancers. 2011; 3(1):1232-1252.
Chicago/Turabian StyleNguyen, Giang Huong; Murph, Mandi M.; Chang, Joe Y. 2011. "Cancer Stem Cell Radioresistance and Enrichment: Where Frontline Radiation Therapy May Fail in Lung and Esophageal Cancers." Cancers 3, no. 1: 1232-1252.